Profile data is unavailable for this security.
About the company
Inno-Gene SA is a Poland-based holding company engaged in management of a portfolio of companies active in life-science sector through the technology, research and development. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
- Revenue in PLN (TTM)462.00k
- Net income in PLN-6.12m
- Incorporated2010
- Employees27.00
- LocationHyenergy SAul. Sciegiennego 20POZNAN 60-128PolandPOL
- Phone+48 616468585
- Fax+48 616232526
- Websitehttp://www.inno-gene.pl/
More ▼
Mergers & acquisitions
| Acquired company | IGN:WSE since announced | Transaction value |
|---|---|---|
| Hydrogenium PSA | 7.14% | 25.88m |
Data delayed at least 15 minutes, as of Nov 12 2024.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sygnis SA | 12.42m | -5.52m | 10.60m | 34.00 | -- | 0.2946 | -- | 0.8537 | -0.2396 | -0.2396 | 0.5314 | 1.43 | 0.1752 | 0.6194 | 15.06 | 326,799.50 | -7.89 | -5.73 | -14.77 | -8.31 | 60.82 | 56.42 | -45.06 | -21.11 | 0.4425 | -0.7412 | 0.1151 | -- | -33.38 | 44.26 | -241.23 | -- | 39.45 | -- |
| Stem Cells Spin SA | 223.67k | -353.29k | 10.66m | 1.00 | -- | 1.49 | 14.16 | 47.68 | -0.0086 | -0.0086 | 0.0054 | 0.1734 | 0.0163 | 0.0739 | 4.38 | 223,670.00 | -2.58 | -1.14 | -4.18 | -1.93 | 80.24 | 94.37 | -157.95 | -45.36 | 0.0118 | -225.54 | 0.0074 | -- | 68.84 | -4.37 | -680.05 | -- | -52.67 | -- |
| Braster SA | 284.00k | -4.30m | 18.03m | 10.00 | -- | -- | -- | 63.47 | -0.1494 | -0.1494 | 0.0098 | -0.1717 | 0.0135 | 0.0038 | 2.70 | 28,400.00 | -20.43 | -29.93 | -147.09 | -72.54 | 93.66 | 79.59 | -1,513.38 | -1,124.89 | 0.2905 | -2.66 | 1.77 | -- | -88.96 | -18.11 | 28.68 | -- | -- | -- |
| Hyenergy SA | 462.00k | -6.12m | 23.25m | 27.00 | -- | 8.27 | -- | 50.33 | -1.06 | -1.06 | 0.0776 | 0.4535 | 0.0625 | 0.9737 | 1.39 | -- | -82.83 | 1.90 | -115.27 | 2.58 | -44.16 | 76.43 | -1,325.33 | 2.66 | 1.20 | -1.00 | 0.0106 | -- | -93.14 | -16.73 | -2,069.21 | -- | -- | -- |
| Medicofarma Biotech SA | 1.37m | -2.73m | 26.17m | -- | -- | 3.01 | -- | 19.12 | -0.0402 | -0.0402 | 0.0201 | 0.128 | 0.0895 | 4.57 | 4.74 | -- | -17.87 | -15.05 | -23.82 | -18.17 | 81.92 | 29.92 | -199.65 | -42.86 | 0.8394 | -18.90 | 0.00 | -- | -82.34 | -31.48 | -116.39 | -- | -- | -- |
| GENOMED SA | 22.14m | 588.66k | 34.62m | 44.00 | 58.81 | 3.73 | 28.99 | 1.56 | 0.4455 | 0.4455 | 16.75 | 7.02 | 2.17 | 5.85 | 14.12 | 503,111.40 | 5.77 | 7.77 | 6.39 | 9.19 | 44.00 | 38.53 | 2.66 | 3.87 | 4.64 | 30,446.00 | 0.00 | -- | 9.88 | 3.88 | 174.07 | -8.94 | -32.19 | -- |
| Read Gene SA | 11.63m | -1.00m | 56.83m | 11.00 | -- | 30.45 | -- | 4.89 | -0.1084 | -0.1084 | 1.16 | 0.1583 | 0.9731 | 51.32 | 18.69 | -- | -8.40 | -1.06 | -8.56 | -1.31 | 92.67 | 88.41 | -8.63 | -2.42 | 23.52 | -2.46 | 0.00 | -- | 40.14 | 16.00 | -731.53 | -- | -- | -- |
| Pure Biologics SA | 68.00k | -23.01m | 70.84m | 11.00 | -- | -- | -- | 1,041.79 | -7.09 | -8.27 | 0.0211 | -1.82 | 0.0016 | -- | 0.469 | 1,333.33 | -53.52 | -65.91 | -85.74 | -109.50 | -1,457.35 | 6.97 | -33,838.23 | -487.38 | -- | -7.36 | -- | -- | -85.65 | -60.22 | -39.41 | -- | 1.65 | -- |
| Sds Optic SA | 370.00 | -8.98m | 78.29m | -- | -- | -- | -- | 211,591.80 | -1.52 | -1.52 | 0.00006 | -0.0545 | 0.00003 | 65.75 | 0.0006 | -- | -74.69 | -- | -86.32 | -- | -371,002.80 | -- | -2,452,795.00 | -- | 9.61 | -47.49 | -- | -- | -99.61 | -- | -85.09 | -- | -- | -- |
| Nanogroup SA | 1.02k | -7.12m | 87.39m | -- | -- | 9.38 | -- | 85,681.36 | -0.3541 | -0.3541 | 0.00005 | 0.3253 | 0.00007 | 7.84 | 0.0141 | -- | -45.22 | -23.18 | -51.42 | -26.06 | -99,397.06 | -278.03 | -692,468.60 | -1,567.57 | 2.75 | -858.81 | 0.00 | -- | -98.55 | -55.07 | -840.84 | -- | -8.99 | -- |
| Genomtec SA | 2.00k | -11.00m | 96.35m | -- | -- | 8.20 | -- | 48,173.49 | -0.8971 | -0.8971 | 0.0002 | 0.9582 | 0.00009 | 62.24 | 0.0011 | -- | -47.25 | -- | -60.10 | -- | -115,050.00 | -- | -549,850.00 | -- | 2.06 | -88.39 | 0.1442 | -- | -97.50 | -- | 24.44 | -- | -- | -- |
Data as of Nov 12 2024. Currency figures normalised to Hyenergy SA's reporting currency: Polish New Zloty PLN
